Skillz Inc. (SKLZ) Made Misstatements Regarding its Purported Financial Condition and Prospects     Flying Eagle Acquisition Corp., a special purpose acquisition corporation, and Skillz consummated their merger on December 16,

AcelRx Therapeutics, Inc. (ACRX) Made Misstatements in Advertising for its Lead Drug Candidate DSUVIA   During the relevant period, defendants made false and/or misleading statements and/or failed to disclose that:

Athira Pharma, Inc. (ATHA) Made Misleading Statements Regarding the Research Backing its Drug Candidates   On June 17, 2021, Athira Pharma, Inc. (ATHA) issued a press release announcing that the

Washington Prime Group, Inc. (WPG) Made Misstatements Regarding its Deteriorating Financial Condition During the class period, WPG failed to disclose material adverse facts about the Company’s business, operations, and prospects. 

Home Point Capital Inc. (HMPT) Made Misstatements in its IPO Offering Documents Home Point conducted its IPO on January 29, 2021, selling its stock at $13.00 per share for proceeds

Tarena International, Inc. (TEDU) Made Misstatements Regarding its Accounting Practices During the class period, defendants made false and misleading statements and/or failed to disclose that: (1) certain employees were interfering

Aterian, Inc. (ATER) Made Misstatements Regarding its Business Prospects   On December 1, 2020, the Company announced that it had acquired the assets of “leading e-commerce business brands Mueller, Purstream,

Washington Prime Group, Inc. (WPG) Made Misstatements Regarding its Deteriorating Financial Condition During the class period, WPG failed to disclose material adverse facts about the Company’s business, operations, and prospects. 

Frequency Therapeutics, Inc. (FREQ) Made Misstatements Regarding the Potential of its Hearing Loss Treatment FX-322   Frequency Therapeutics began its Phase 2a trial for FX-322 in October 2019.  The trial